Sort   by:  
 Page size 
UnknownBiological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis.
Not available
S-EPMC9788816 | biostudies-literature
UnknownBiomarkers of endothelial dysfunction and cognition: A two-step IPD meta-analysis.
Not available
S-EPMC11667552 | biostudies-literature
UnknownPopulation-based screening in a municipality after a primary school outbreak of the SARS-CoV-2 Alpha variant, the Netherlands, December 2020-February 2021.
Not available
S-EPMC9612486 | biostudies-literature
UnknownHumoral and cellular immune responses after COVID-19 vaccination of lung transplant recipients and patients on the waiting list: a 6-month follow-up.
Not available
S-EPMC10794507 | biostudies-literature
UnknownGenetics of early-life head circumference and genetic correlations with neurological, psychiatric and cognitive outcomes.
Not available
S-EPMC9166310 | biostudies-literature
UnknownHand function impairment in Systemic sclerosis: Outcomes, Mechanisms and Experience (HANDSOME) - a longitudinal observational multicentre study protocol.
Not available
S-EPMC11907010 | biostudies-literature
UnknownCommon genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis.
Not available
S-EPMC4217133 | biostudies-literature
UnknownA randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol.
Not available
S-EPMC6104757 | biostudies-literature
UnknownA screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC score.
Not available
S-EPMC12671881 | biostudies-literature
UnknownA phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's.
Not available
S-EPMC11781579 | biostudies-literature
Sort   by:  
 Page size